Statement from the American Association of Nurse Anesthesiology (AANA) President Jeff Molter, MSN, MBA, CRNA, on the recent decision from the U.S. Court of Appeals for the Sixth Circuit
Statement from the American Association of Nurse Anesthesiology (AANA) President Jeff Molter, MSN, MBA, CRNA, on the recent decision from the U.S. Court of Appeals for the Sixth Circuit
PR Newswire
ROSEMONT, Ill., July 21, 2026
ROSEMONT, Ill., July 21, 2026 /PRNewswire/ -- "We disagree with today's ruling and are disappointed that the court will not compel the Department of Health and Human Services (HHS) to enforce the provider nondiscrimination provision of the Affordable Care Act, which was later reinforced in the bipartisan No Surprises Act," said AANA President Jeff Molter, MSN, MBA, CRNA. "HHS should have acted years ago.
The decision relies heavily on the court's interpretation of associational standing, finding that the initial ruling that AANA lacked standing was correct. Associational standing is a core tenet of professional and trade associations seeking to protect the interests of their members. AANA is evaluating the decision's implications for how associations vindicate their members' interests in federal court, and we encourage all associations to do the same.
This decision does not validate the behavior of insurance companies and their practice of reduced reimbursement for Certified Registered Nurse Anesthetists (CRNA) provided services. AANA maintains that reducing such reimbursement for the same services provided by physician anesthesiologists is discriminatory and inconsistent with the protections Congress enacted. Today's decision was procedural and does not endorse the insurance companies' payment practices. AANA maintains that such practices remain unlawful under current statute.
AANA remains focused on working with our state partners to create local momentum that would protect CRNAs from discriminatory reimbursement practices while we explore future federal pathways."
SOURCE American Association of Nurse Anesthesiology
The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
5 Stocks to Sell for Tax-Loss Harvesting
33 Undervalued Stocks to Buy Before the Market Shifts Again
The Smartest Moves for Bond Investors Today, and What to Do When You Have Too Many Investments
Ask the Analyst: What Is the Best Source for Low-Risk Tax-Free Income?
United States